Stay updated with breaking news from Nasdaq Surf. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analysts expect that Surface Oncology, Inc. (NASDAQ:SURF – Get Rating) will report earnings per share of ($0.48) for the current quarter, according to Zacks. Zero analysts have made estimates for Surface Oncology’s earnings, with the highest EPS estimate coming in at ($0.38) and the lowest estimate coming in at ($0.54). Surface Oncology posted earnings per […]
Surface Oncology (NASDAQ:SURF – Get Rating) and Monte Rosa Therapeutics (NASDAQ:GLUE – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation. Valuation & Earnings This table compares Surface Oncology […]
Wall Street analysts expect that Surface Oncology, Inc. (NASDAQ:SURF – Get Rating) will announce earnings per share (EPS) of ($0.48) for the current quarter, according to Zacks. Zero analysts have issued estimates for Surface Oncology’s earnings. The highest EPS estimate is ($0.38) and the lowest is ($0.54). Surface Oncology posted earnings of ($0.37) per share […]
Strs Ohio lifted its position in shares of Surface Oncology, Inc. (NASDAQ:SURF – Get Rating) by 9.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 133,500 shares of the company’s stock after buying an additional 11,900 shares during the […]
Equities research analysts predict that Surface Oncology, Inc. (NASDAQ:SURF – Get Rating) will post earnings of ($0.48) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for Surface Oncology’s earnings. The highest EPS estimate is ($0.38) and the lowest is ($0.54). Surface Oncology reported earnings per share of […]